You are here

  • Home
  • Archive
  • Volume 66, Issue 8
  • The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS

Article info

Article menu
Download PDFPDF
Neurogastroenterology
Original article
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS

Authors

  1. Correspondence to Professor Jan Tack, Division of Gastroenterology, TARGID, University of Leuven, University Hospital Gasthuisberg, Herestraat 49, Leuven B-3000, Belgium; jan.tack{at}med.kuleuven.be
View Full Text

Citation

Tack J, Schumacher K, Tonini G and the Iris-2 investigators, et al
The neurokinin-2 receptor antagonist ibodutant improves overall symptoms, abdominal pain and stool pattern in female patients in a phase II study of diarrhoea-predominant IBS
Gut 2017;66:1403-1413.
Online issue publication 
October 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/